252 related articles for article (PubMed ID: 14578862)
41. Usefulness of prophylactic transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Togo S; Tanaka K; Masui H; Matsuo K; Morioka D; Kurosawa H; Miura Y; Endo I; Sekido H; Shimada H
Int Surg; 2005; 90(2):103-8. PubMed ID: 16119716
[TBL] [Abstract][Full Text] [Related]
42. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study.
Niguma T; Mimura T; Tutui N
J Hepatobiliary Pancreat Surg; 2005; 12(3):249-53. PubMed ID: 15995815
[TBL] [Abstract][Full Text] [Related]
43. Surgical treatment and adjuvant chemotherapy in hepatocellular carcinoma patients with advanced vascular involvement.
Nanashima A; Sumida Y; Abo T; Nagasaki T; Ohba K; Kinoshita H; Tobinaga S; Kenji T; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(82-83):627-32. PubMed ID: 18613421
[TBL] [Abstract][Full Text] [Related]
44. Lipiodolization prolongs survival rates in postoperative patients with a recurrent hepatocellular carcinoma.
Furuta T; Kanematsu T; Matsumata T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
Hepatogastroenterology; 1990 Oct; 37(5):494-7. PubMed ID: 2174829
[TBL] [Abstract][Full Text] [Related]
45. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
Launois B; Maddern G
Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
[No Abstract] [Full Text] [Related]
46. Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection.
Chan KM; Lee WC; Hung CF; Yu MC; Jan YY; Chen MF
Chang Gung Med J; 2005 Aug; 28(8):543-50. PubMed ID: 16265844
[TBL] [Abstract][Full Text] [Related]
47. Treatment of unresectable hepatocellular carcinoma with radiolabelled lipiodol.
Kanhere HA; Leopardi LN; Fischer L; Kitchener MI; Maddern GJ
ANZ J Surg; 2008 May; 78(5):371-6. PubMed ID: 18380736
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant treatments for resectable hepatocellular carcinoma.
Ishii H; Yamamoto J; Ikari T
J Hepatobiliary Pancreat Surg; 2008; 15(5):459-62. PubMed ID: 18836796
[TBL] [Abstract][Full Text] [Related]
49. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
[TBL] [Abstract][Full Text] [Related]
50. Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival.
Dupont-Bierre E; Compagnon P; Raoul JL; Fayet G; de Lajarte-Thirouard AS; Boudjema K
J Am Coll Surg; 2005 Nov; 201(5):663-70. PubMed ID: 16256907
[TBL] [Abstract][Full Text] [Related]
51. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
52. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
53. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
[TBL] [Abstract][Full Text] [Related]
54. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
55. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.
Hui D; Qiang L; Jian W; Ti Z; Da-Lu K
Dig Liver Dis; 2009 Jan; 41(1):36-41. PubMed ID: 18818130
[TBL] [Abstract][Full Text] [Related]
56. Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy.
Ueno M; Uchiyama K; Ozawa S; Hayami S; Shigekawa Y; Tani M; Yamaue H
Ann Surg Oncol; 2011 Dec; 18(13):3624-31. PubMed ID: 21614626
[TBL] [Abstract][Full Text] [Related]
57. Hepatic resection compared to percutaneous ethanol injection for small hepatocellular carcinoma using propensity score matching.
Cho YB; Lee KU; Suh KS; Kim YJ; Yoon JH; Lee HS; Hahn S; Park BJ
J Gastroenterol Hepatol; 2007 Oct; 22(10):1643-9. PubMed ID: 17845692
[TBL] [Abstract][Full Text] [Related]
58. [Clinical study of adjuvant individualized chemotherapy for hepatocellular carcinoma after liver transplantation].
Chen GH; Lu MQ; Cai CJ; Yang Y; He XS; Zhu XF
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1040-3. PubMed ID: 15498315
[TBL] [Abstract][Full Text] [Related]
59. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
Covey AM; Maluccio MA; Schubert J; BenPorat L; Brody LA; Sofocleous CT; Getrajdman GI; Fong Y; Brown KT
Cancer; 2006 May; 106(10):2181-9. PubMed ID: 16596622
[TBL] [Abstract][Full Text] [Related]
60. Experience with more than 500 minimally invasive hepatic procedures.
Buell JF; Thomas MT; Rudich S; Marvin M; Nagubandi R; Ravindra KV; Brock G; McMasters KM
Ann Surg; 2008 Sep; 248(3):475-86. PubMed ID: 18791368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
